Nevada HIV: Stigma, Discrimination and Bias

Course Overview

Course Outline

1. Introduction  
2. Overview of Human Immunodeficiency Virus (HIV) 
3. The Devastation of an HIV Diagnosis 
4. Facts and Myths 
5. Forms of Discrimination in Healthcare 
6. Federal and Nevada State Laws Regarding HIV Discrimination 
7. Ethical Principles in Healthcare: Autonomy, Beneficence, Non-Maleficence, Justice 
8. Reducing Stigma and Discrimination 
9. Advocacy and Policy

Accreditation Statement

Nursing CE Central LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

In this course, we will discuss updates to the nurse’s role in HIV care in Nevada. It will take the average learner 120 minutes to complete and awards 2 contact hours of continuing education.

Course Outcomes

After completing this course, the learner will rate a 4 out of 5 on the Likert Scale for their ability to:

1. Understand the legal protections against discrimination for patients who are HIV-positive in Nevada and the United States. 
2. Recognize the forms of HIV discrimination in healthcare settings. 
3. Apply ethical principles in the care of patients who are HIV-positive. 
4. Employ effective communication strategies that respect patient privacy and promote trust. 
5. Develop strategies to reduce stigma and discrimination within your practice and workplace. 
6. Advocate for the rights and equitable treatment of patients who are HIV-positive.

Target Audience

• Registered Nurses (RN)
• Advanced Practice Registered Nurses (APRN)
• Licensed Practical Nurses (LPN/LVN)

Requirement for Completion

1. Enrollment in the course by the learner
2. Read and learn all course materials
3. Complete the course evaluation
4. Attest and testify learning of the course materials

Accreditations + Approvals

Disclosure of Relevant Financial Relationships

Nursing CE Central nor any of the authors, planners, content experts, or any contributors have any relevant financial relationships with ineligible companies to disclose.